The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 21, 2022
The US FDA issued warning letters to seven companies for illegally selling dietary supplements that claim to cure, treat, mitigate or prevent ...
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more
Tuesday, January 10, 2023
Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API...
read more
Wednesday, March 01, 2023
The FDA announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage form drug ...
read more
Camber Pharmaceuticals is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the ...
read more
Thermo Fisher Scientific has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines ...
read more
OBiO Technology Corp., Ltd., a gene and cell therapy CDMO in China, and Univercells Technologies, a lprovider of novel biomanufacturing technologies ...
read more
Lifera, a biopharmaceutical company in Saudi Arabia together with Sanofi, and Arabio announced the signing of a Memorandum of Understanding (MOU), ...
read more
Thursday, August 17, 2023
Croda Pharma introduced a range of new bioprocessing detergents optimised for viral inactivation and cell lysis.
read more
Thursday, August 17, 2023
The life science group Sartorius and Repligen Corporation announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ...
read more
Tuesday, September 19, 2023
Nexcella, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other ...
read more
Wednesday, October 11, 2023
Family Dollar is initiating a voluntary retail-level product recall of certain over-the-counter drugs and medical devices regulated by the FDA.
read more
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
read more
Haleon is voluntarily recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult to the consumer level. The...
read more
Wednesday, January 31, 2024
Rapid Micro Biosystems, Inc
Rapid Micro Biosystems announced that it expects the commercial launch of the Growth Direct Rapid Sterility application by mid-year 2024.
read more